Diffusion Pharmaceuticals Inc.·4

Jan 30, 9:06 AM ET

Byrne Thomas E 4

4 · Diffusion Pharmaceuticals Inc. · Filed Jan 30, 2019

Insider Transaction Report

Form 4
Period: 2019-01-02
Byrne Thomas E
General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-01-03+2,6672,667 total
    Exercise: $2.10Exp: 2029-01-02Common Stock (2,667 underlying)
Footnotes (1)
  • [F1]The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2019.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4